New Landmark Report Unveils a Decade of AI Transformation in Drug Discovery
In a first-of-its kind analysis, BiopharmaTrend is excited to announce the release of its seminal report, "It’s Been a Decade …
News
AI Integration Advances Lung Fibrosis Patient Stratification in Clinical Trials
In a collaborative effort between Brainomix, an AI-powered medical technology company, and AstraZeneca, a new study demonstrates significant advancements in …
Denmark Collaborates with NVIDIA to Establish AI Innovation Centre Featuring Advanced Supercomputer
Denmark is set to create a national AI innovation centre in collaboration with NVIDIA, aiming to host one of the …
Basecamp Research Introduces BaseFold, Enhancing Accuracy in Protein Structure Prediction
Basecamp Research announced the development of BaseFold, a new deep learning model designed to predict the 3D structures of large, …
Recursion Expands Its Presence with a New London Office and Bolsters Scientific Advisory Team
Recursion (NASDAQ: RXRX), a clinical-stage TechBio company, has unveiled plans to establish a new office in London's King’s Cross area, …
Elsevier and Iktos Collaborate to Boost Drug Discovery with AI-Enhanced Chemistry Database
Elsevier, a global provider of information and analytics in science and health with 140 years of history, has entered into …
Towards 100 Billion Data Points for Advanced Drug Discovery and Treatment Combinations
Lantern Pharma, a NASDAQ-listed company specializing in AI-driven cancer drug discovery and development, has announced a milestone with its artificial intelligence platform …
Sam Altman-backed Startup Partners with Microsoft to Enable the AI Infrastructure for Drug Discovery
A new five-year commercial agreement and go-to-market collaboration aims to merge 1910 Genetics' comprehensive computational and biological data with Microsoft’s HPC …
A Busy Day for Ginkgo Bioworks
It is a remarkable day for Ginkgo Bioworks, a notable player in the field of synthetic biology, as the company …
Curve Therapeutics Adds £10 Million for Its Intracellular Screening Platform
British Patient Capital has invested £10m in Southampton-based biotechnology firm Curve Therapeutics through its Future Fund: Breakthrough programme and co-investment …
Using Quantum-Enhanced AI to Design Novel KRAS Inhibitors
In a collaborative effort, Zapata Computing (Zapata AI), together with Insilico Medicine, the University of Toronto, and St. Jude Children's …
A Novel Cancer Therapy Targeting KIF18A with AI-Designed Compound
Insilico Medicine, a leader in AI-driven drug discovery, has developed a new preclinical candidate, ISM9682, aimed at treating advanced solid …